Worth reading
66In focus
Scored from 3 of 5 sectionsDirection
Neutral
Direction inferred from the company’s description.Scale
50000
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Report on the exercise status of the 17th Series Stock Acquisition Rights issued through a third-party allotment (with an option to adjust the exercise price)
発行・処分する株式数50,000Shares
50,000 new shares
Intended allottee
Cantor Fitzgerald Europe (the allottee of the previously issued stock acquisition rights)
発行済株式総数
The 50,000 shares issued in this transaction, relative to the 8,912,700 shares outstanding at the end of the previous month: approximately 0.56%
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
Terms of the stock acquisition rights
Exercise price
¥1,070 per share. Details of the adjustment provisions and the adjustment floor: Not disclosed
Number of Stock Acquisition Rights
Total issued: 1,608; exercised in this transaction: 500; currently unexercised: 108
Most recent equity financing
The 17th Stock Acquisition Rights issued on 26 December 2025, with Cantor Fitzgerald Europe as the allottee (with an option to adjust the exercise price)
| Item | Details |
|---|---|
| Type of issuance or disposal | Report on the exercise status of the 17th Series Stock Acquisition Rights issued through a third-party allotment (with an option to adjust the exercise price) |
| Number of shares to be issued or disposed of | 50,000 new shares |
| Intended allottee | Cantor Fitzgerald Europe (the allottee of the previously issued stock acquisition rights) |
| Dilution Rate | The 50,000 shares issued in this transaction, relative to the 8,912,700 shares outstanding at the end of the previous month: approximately 0.56% |
| Total number of issued shares | 8,912,700 shares (as of the end of the month preceding the relevant month) → Not disclosed |
| Exercise price | ¥1,070 per share. Details of the adjustment provisions and the adjustment floor: Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 1,608; exercised in this transaction: 500; currently unexercised: 108 |
| Most recent equity financing | The 17th Stock Acquisition Rights issued on 26 December 2025, with Cantor Fitzgerald Europe as the allottee (with an option to adjust the exercise price) |
Items this document does not state (20)
Issue price and disposal priceTotal issue valueAmount of funds to be raisedEstimated issuance expensesSpecific use of fundsPayment dateIntended allottee's holding policyBasis for determining the amount to be paidExercise periodTransfer restriction periodConditions for lifting transfer restrictionsReason for acquisition without considerationCategories and Number of Persons CoveredTotal Stock-Based CompensationUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMajor shareholders after the offeringImpact on Business Performance
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the large-scale exercise of these Stock Acquisition Rights on 14 May 2026.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.